David R. Bauer
Lawyers
Filters
Roche acquisition of SAGA Diagnostics
We advised Roche on the transaction
Editas Medicine $125 million follow-on offering
We advised the joint book-running managers on the offering
Immix Biopharma $150 million stock offering
We advised the lead bookrunner and the underwriters on the offering
Neptune $300 million follow-on offering
We advised the underwriters on the offering
Oruka Therapeutics collaboration with Halozyme
We advised Oruka Therapeutics on the transaction
Purdue Pharma completes chapter 11 restructuring
We advised Purdue in connection with its nearly seven year-long chapter 11 restructuring
GH Research $200 million at-the-market offering
We advised GH Research on the establishment of the at-the-market program
Tempus AI $460 million convertible senior notes offering
We advised the representatives of the several initial purchasers on the offering
Alector $125 million at-the-market offering
We advised the sales agent on the offering
Roche acquisition of PathAI
We are advising Roche on the transaction